Biotech Values

[DewDiligence]

If you’re going to complain about insider selling, you ought to call out companies where insider sales comprise a material amount of money rather than a company like MNTA where insiders sell a few hundred shares at a time.

One such company is CLB, where five insiders sold a cumulative $29M worth of stock in July (#msg-65765284). Paradoxically, CLB has better business metrics than any company I follow (with the possible exception of MNTA) and has been one of the best performing stocks in my portfolio during the past couple of years.

I never like insider selling of any kind; on the other hand, one can easily become over-focused on insider selling, which is what you seem to have done with MNTA.